AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Jun 8, 2012
31971_dirs_2012-06-08_fdea8501-2fe7-4f0b-8509-070175461f67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-06
Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-06 | Common Stock | M | 2000 | $16.46 | Acquired | 11406 | Direct |
| 2012-06-06 | Common Stock | F | 1508 | $26.85 | Disposed | 9898 | Direct |
| 2012-06-06 | Common Stock | M | 2000 | $19.26 | Acquired | 11898 | Direct |
| 2012-06-06 | Common Stock | F | 1640 | $26.85 | Disposed | 10258 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-06 | Sars (Stock Appreciation Rights) | $16.46 | M | 2000 | Disposed | 2019-06-01 | Common Stock (2000) | Direct |
| 2012-06-06 | Sars (Stock Appreciation Rights) | $19.26 | M | 2000 | Disposed | 2020-06-01 | Common Stock (2000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7